ImmuCell
ICCC
ICCC
29 hedge funds and large institutions have $8.53M invested in ImmuCell in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
7% less capital invested
Capital invested by funds: $9.18M → $8.53M (-$650K)
Holders
29
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$817K | |
| 2 | +$265K | |
| 3 | +$14.1K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.8K |
| 5 |
BlackRock
New York
|
+$7.77K |
Top Sellers
| 1 | -$90K | |
| 2 | -$13.5K | |
| 3 | -$10K | |
| 4 |
Renaissance Technologies
New York
|
-$6.88K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$6.03K |